-
Cognitive impairment in adult inflammatory bowel disease: a systematic review and meta-analysis Psychosomatics (IF 3.4) Pub Date : 2021-01-05 Christopher W.P. Hopkins, Nick Powell, Christine Norton, Jonathan L. Dumbrill, Bu’Hussain Hayee, Calum D. Moulton
Background People living with inflammatory bowel disease (IBD) are exposed to multiple risk factors for cognitive impairment and frequently report cognitive difficulties. However, the presence of cognitive impairment in IBD has not been systematically evaluated. Methods Following PRISMA guidelines, we performed a systematic multi-database search for cross-sectional- and longitudinal studies comparing
-
Guanfacine for hyperactive delirium: A case series Psychosomatics (IF 3.4) Pub Date : 2020-11-13 Shixie Jiang, Richard Czuma, Alexis Cohen-Oram, Kimberly Hartney, Theodore A. Stern
Background Hyperactive delirium is difficult to manage in hospitalized medically ill individuals. Although antipsychotics have long been used for symptomatic management of delirious agitation, their use has been scrutinized recently due to significant adverse effects. Alpha-2 agonists, such as dexmedetomidine and clonidine, have demonstrated efficacy in the prevention and management of delirium; however
-
Intravenous Lorazepam Infusions for Dissociative Amnesia: A Case Report Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Shixie Jiang, Steven Gunther, Kimberly Hartney, Theodore A. Stern
Abstract: A 20-year-old woman with no prior psychiatric and medical history presented with acute autobiographical memory loss and a psychogenic tremor. Her laboratory and imaging work-up revealed no infectious, inflammatory, or other organic etiologies. A lorazepam infusion-assisted interview successfully facilitated recovery of memories and elucidated precipitating events. We discuss the utility of
-
Adaptation of an Academic Inpatient Consultation-Liaison Psychiatry Service during the SARS-CoV-2 Pandemic: Effects on Clinical Practice and Trainee Supervision Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Christine Beran, Nathaniel A. Sowa
Introduction The SARS-CoV-2 pandemic has led to drastic changes in how psychiatric consultation liaison (CL) services conduct business and required rapid transition to telepsychiatry. We describe the practice changes implemented to rapidly transition to virtual care in a large, academic psychiatry CL service in response to the pandemic. Objective To describe clinical service structural changes, timelines
-
I Have to Pay to Use the MoCA? What Should I Do? Psychosomatics (IF 3.4) Pub Date : 2020-11-01 David Mansoor, Deniz Erten-Lyons
BACKGROUND For many years, the Montreal Cognitive Assessment (MoCA) has been one of the most commonly used cognitive screening instruments in ambulatory care settings. Because the MoCA will no longer be in the free public domain by the end of 2020, it is important to consider cognitive screening tests that are comparable and free. METHODS We briefly review three cognitive screening instruments, the
-
Dermatitis neglecta, the cognitive assessment, and micronutrients. Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Thomas M. Brown
Abstract One of the joys of psychosomatic medicine is the search for relevant data wherever it can be found. Sometimes an unexpected finding contributes greatly to the psychiatric assessment. Skin findings are among the data not usually sought in the mental status examination, but which can add to a patient’s story. Dermatitis neglecta (DN) is such a finding. Although DN has never been linked to cognitive
-
Neuropsychiatric Symptoms in an Adolescent Boy with Multisystem Inflammatory Syndrome in Children (MIS-C) Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Lisa Hutchison, Anna M. Plichta, Yehuda Lerea, Marlee Madora, H. Michael Ushay
Abstract Background Multisystem Inflammatory Syndrome in Children (MIS-C) related to coronavirus disease-2019 (COVID-19) is an emergent syndrome affecting children globally in the wake of the SARS-CoV-2 pandemic. The clinical presentation has similarities to Kawasaki disease and toxic shock syndrome. As knowledge of the cardiac and gastrointestinal manifestations has been emerging, little is known
-
Diagnostic Challenges and Treatment of the Neuropsychiatric Symptoms of Adult Onset Niemann-Pick Type C with Electroconvulsive Therapy Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Rachel Foels, Kimberly Hartney, Alexis Cohen-Oram
Abstract Adult onset Niemann- Pick disease type C (NPC) is a rare autosomal recessive lysosomal storage disorder that presents with heterogenous neuropsychiatric symptoms. Because of the variation of presentations, the diagnosis is often delayed or overlooked. Another treatment challenge is that currently there is only one FDA approved treatment, Miglustat, a reversible glycosphingolipid synthesis
-
The Use of Security Dogs in De-Escalation of Agitated Patients Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Janice Chung, Prudhvi Bandi, Daniel B. Janiczak, Jason P. Caplan, Curtis A. McKnight
Abstract Violence, aggression, and agitation are widely reported in both psychiatric and general hospital settings and are challenging clinical scenarios. A stepwise approach beginning with verbal de-escalation progressing to other measures such as medication, constant observation, and restraints is a standard approach with variable efficacy. Another approach to the management of agitation and aggression
-
Can Memantine Improve Catatonia and Co-Occurring Cognitive Dysfunction? A Case Report and Brief Literature Review Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Julie Graziane, Erin Davidowicz, Andrew Francis
Abstract Background In addition to the motor and behavioral symptoms of catatonia, an emerging literature describes co-occurring cognitive dysfunction with catatonia. Memantine is an NMDA receptor antagonist used for some neurocognitive disorders and off-label for catatonia. Objective The objective of this case report is to demonstrate improvement of catatonic symptoms and co-occurring cognitive dysfunction
-
Mania associated with supratherapeutic tacrolimus levels in a patient with no psychiatric history Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Sindhura Vangala, Ganj Beebani, Rachel Thiem, Aimee Dereczyk
Abstract Neurological side effects of tacrolimus have been well documented in the literature, while psychiatric symptomatology, especially mania, have rarely been reported. We report the case of a 64 year old man with no psychiatric history who developed mania with supratherapeutic serum concentrations of tacrolimus. The patient was treated with a mood stabilizer and an atypical antipsychotic while
-
Stercoral perforation in a patient on suboxone treatment Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Teryn Igawa, Faiza Farooq, Yvette Smolin
Background Opioids are a common cause of constipation, which can lead to fecal impaction, colonic ulceration, necrosis, and perforation. Although uncommon, stercoral perforation is a serious complication and carries high rates of morbidity and mortality. Prompt surgical intervention is essential to optimize outcomes. Case Presentation We present a 33-year-old Caucasian female who was transferred for
-
CASPR2 IgG Associated Autoimmune Encephalitis: Unusual Cause of Delirium Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Qi Sun, Tara Davidson, Jennifer Kleinman Sween, Christopher Klein, Thomas McLeod, Teresa Rummans
Abstract: Background Delirium is one of the most prevalent conditions seen in older patients. Some of the newer known causes of delirium involve the body’s immune system attacking healthy brain cells, leading to inflammation of the brain known as autoimmune encephalitis. Method We herein report the case of an 80-year-old man presenting with progressive confusion, hallucinations, behavioral changes
-
Clonidine and Tizanidine for Management of Bipolar Disorder due to Dengue Encephalopathy: A Case Report Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Pornjira Pariwatcharakul, Maytinee Srifuengfung
Abstract Background Dengue is a common mosquito-borne viral infection worldwide. Manic episode due to dengue encephalopathy is a rare complication of this infection. Patients with brain lesion may be more susceptible to developing extrapyramidal symptoms (EPS) from antipsychotics. Here, we present the first reported case of the use of alpha-2 adrenergic receptor (α2AR) agonists, clonidine and tizanidine
-
Delirium following withdrawal from Valerian root: A case report Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Heather Burke, Shixie Jiang, Peggy Chatham, Theodore A. Stern
Abstract: Background Valerian root is an herbal supplement used for its anxiolytic and sedative properties. Its extract is thought to serve as an allosteric modulator of gamma-aminobutyric acid A, which can cause delirium due to its influence on the nervous system’s inhibitory tone and its effect on the sleep-wake cycle. Objective This report presents a patient who developed delirium secondary to withdrawal
-
The Incapacitated Surrogate: What is the Consultation Liaison Psychiatrist’s Role? Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Nicole Allen, Adrienne Mishkin
BACKGROUND When a patient is found to be lacking capacity to make a medical decision, the medical team is advised to turn to the patient's most appropriate surrogate decision maker (hereafter, surrogate) to make a choice on behalf of the patient. The assumption made by the medical team is that the surrogate will have the capacity to make appropriate medical decisions on behalf of the patient. At times
-
Optimizing Fit: Targeting a Residency Psychiatry Consultation-Liaison Rotation to Various Levels of Training Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Scott R. Beach, Daniel Shalev, Steven V. Fischel, Robert J. Boland, Carrie L. Ernst
Abstract Introduction Determining the optimal timing and structure for a core residency rotation in consultation-liaison psychiatry (CLP) remains a key challenge for program directors and rotation leaders. Previous surveys have been conducted regarding these questions and guidelines from national organizations have been issued, but practices remain varied among institutions. Methods We conducted a
-
Medical Complications of Anorexia Nervosa Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Kamila Cass, Colleen McGuire, Ida Bjork, Nicole Sobotka, Kristine Walsh, Philip S. Mehler
OBJECTIVE The purpose of this study was to describe the medical complications of anorexia nervosa (AN) to enable a consult-liaison psychiatrist to be familiar with these complications when involved with the care of a hospitalized patient with AN. METHODS Comprehensive PubMed search of English language publications of adult patients with AN was carried out using keywords, phrases, and medical subject
-
Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of COVID-19: Psychopharmacological Interactions and Neuropsychiatric Sequelae Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Brandon S. Hamm, Lisa J. Rosenthal
ABSTRACT Background Chloroquine and hydroxychloroquine are among several experimental treatments being investigated in the urgent response to the COVID-19. With increased use of these medications, physicians need to become knowledgeable of these drugs’ neuropsychiatric side effects and interactions with psychiatric medications. Methods Literature review was performed in PubMed from 1950-2020 regarding
-
VAPING CANNABIS OIL: A CASE OF CATATONIA ASSOCIATED WITH USE OF HIGH-POTENCY CANNABIS Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Tessa Manning, Christine Bartow, Matthew McNaughton, Eric Reynolds, Zephan Chen
Abstract Several troubling trends in cannabis use have converged in recent years. The average concentration of psychoactive tetrahydrocannabinol in cannabis has steadily increased while the concentration of psychoprotective cannabidiol has fallen. 1 This trend coincides with a wave of legalization as well as novel methods for consuming marijuana, quite often in the form of “vaping” concentrated oils
-
Intravenous Misuse of Unsterilized Methamphetamine Bong Water with Methamphetamine Laced with Vape Juice Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Jonathan S. Constant, Sheryl B. Fleisch
Abstract As the prevalence of substance use disorders continue to increase nationally and there are more barriers to access traditional illicit drugs, unique ways to create new compounds and mix existing substances will occur. It is critical that consultation-liaison psychiatry and addiction providers appreciate new, potentially dangerous synthetic drugs and combinations of substances that can result
-
Design and implementation of a regional inpatient psychiatry unit for asymptomatic SARS-CoV-2 positive patients. Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Andrew F. Angelino, Constantine G. Lyketsos, M. Shafeeq Ahmed, James B. Potash, Bernadette A. Cullen
Background Patients with psychiatric illnesses are particularly vulnerable to highly contagious, droplet-spread organisms such as SARS-CoV-2. Patients with mental illnesses may not be able to consistently follow up behavioral prescriptions to avoid contagion, and they are frequently found in settings with close contact and inadequate infection control, such as group homes, homeless shelters, residential
-
Addiction Management in Hospitalized Patients with IV Drug Use Associated Infective Endocarditis Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Vani Ray, Mindy R. Waite, Frank C. Spexarth, Sandra Korman, Susan Berget, Soumya Kodali, David Kress, Neil Guenther, Vishnubhakta S. Murthy
BACKGROUND Infections related to intravenous drug use and opioid use disorders (OUDs) are increasing nationwide. Endocarditis is a recognized complication of intravenous drug use, and inpatient treatment typically focuses on infection management without attention to underlying addiction. OBJECTIVE A comprehensive intervention for inpatients with infective endocarditis and intravenous drug use was implemented
-
Trikafta and Psychopathology in Cystic Fibrosis: A Case Report Psychosomatics (IF 3.4) Pub Date : 2020-11-01 William Tindell, Amanda Su, Sarah M. Oros, Abner O. Rayapati, Gopalkumar Rakesh
Abstract Introduction Patients with cystic fibrosis (CF) have a high prevalence of comorbid anxiety and depressive symptoms, ranging from 8-29% in children and adolescents and 13-33% among adults. There is also a correlation between their physical symptoms and quality of life. A fixed-dose triple combination tablet of the cystic fibrosis transmembrane conductance regulator (CFTR) correctors elexacaftor
-
Coronavirus and its implications for psychiatry: a rapid review of the early literature Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Maximilliam A. Cabrera, Lakshmipriya Karamsetty, Scott A. Simpson
Abstract Background The novel coronavirus pandemic has changed healthcare rapidly and dramatically. We provide a critical synthesis of the scientific literature on the pandemic’s implications for psychiatric practice. Methods A rapid literature review was undertaken to identify scientific literature linking psychiatric outcomes and practice changes due to coronavirus and the disease it causes (COVID-19)
-
Strategies to Mitigate Clinician Implicit Bias against Sexual and Gender Minority Patients Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Michal J. McDowell, Hilary Goldhammer, Jennifer E. Potter, Alex S. Keuroghlian
BACKGROUND Implicit bias is an ingrained, unconscious cultural stereotype that can negatively affect a person's interactions with members of stigmatized groups, including sexual and gender minorities. Clinician implicit biases may negatively impact the quality of patient care. METHODS This article uses 4 case scenarios to illustrate how implicit bias among psychiatrists and other clinicians can affect
-
Proactive C-L psychiatry beyond academic hospital settings: A pilot study of effectiveness in a suburban community hospital. Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Joseph Kugler, Garrett Key, Mark Oldham
BACKGROUND Proactive consultation-liaison psychiatry improves identification of psychiatric needs and reduces time to psychiatric consultation and length of stay (LOS) among medical inpatients in academic clinical settings. OBJECTIVE To evaluate the effect of a proactive model on LOS, consult rate, and consultation latency in a nonacademic community hospital. METHODS We implemented a modified proactive
-
Psychological influence of Coronovirus disease 2019 (COVID-19) pandemic on the general public, medical workers and patients with mental disorders and its countermeasures Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Sanwang Wang, Xin Wen, Yingying Dong, Bin Liu, Minghu Cui
Abstract: Coronovirus disease 2019 (COVID-19) first broke out in Wuhan, Hubei Province, China in 2019, and now it spreads in more than 100 countries around the world. On January 30th, the World Health Organization (WHO) declared COVID-19 a public health emergency (PHEIC) of international concern. It was classified as a pandemic by (WHO) of the World Health Organization on March 11, 2020. With the increase
-
Neurocovid: Pharmacological recommendations for delirium associated with COVID-19 Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Erica B. Baller, Charlotte S. Hogan, Mark A. Fusunyan, Ana Ivkovic, James W. Luccarelli, Elizabeth Madva, Mladen Nisavic, Nathan Praschan, Nadia V. Quijije, Scott R. Beach, Felicia A. Smith
Abstract Background The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as one of the biggest health threats of our generation. A significant portion of patients are presenting with delirium and neuropsychiatric sequelae of the disease. Unique exam findings and responses to treatment have been identified. We seek to
-
The Feasibility and Impact of a Suicide Risk Screening Program in Rural Adult Primary Care: A Pilot Test of the Ask Suicide-Screening Questions Toolkit Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Mary A. LeCloux, Mathew Weimer, Stacey L. Culp, Karissa Bjorkgren, Samantha Service, John V. Campo
OBJECTIVE The purpose of this study was to evaluate the feasibility and impact of a suicide risk screening program in a rural West Virginia primary care practice. METHODS Patients presenting for routine and sick visits were asked to participate in electronic suicide risk screening using the Ask Suicide-Screening Questions tool; screen positive individuals were assessed with the Ask Suicide-Screening
-
A Multidisciplinary Consultation Liaison Team Approach to Reduce Enhanced Observer Usage Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Stacy L. Kracher, Andrew Currivan, Maria Guerrero, Deborah Goebert, James R. Agapoff, Bradley Kuo, Earl Hishinuma, Chelsea Wong, Me Fuimaono-Poe
BACKGROUND There are few evidence-informed guidelines and findings to show that the use of sitters improves patient safety; overall, it is a costly intervention to address patients with disruptive behaviors. OBJECTIVE The purpose of this article is to demonstrate that the creation of a multidisciplinary consultation-liaison (C-L) team, integrated with a psychiatric C-L team, together can decrease sitter
-
Pseudodementia Is Not Always Pseudo: Differentiating pseudodementia from Korsakoff’s dementia in a case of severe depression Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Jacqueline G. Posada, Evan B. Hughes, Thomas N. Wise, Christopher Willis
Abstract Background Non-alcoholic-Wernicke-Korsakoff syndrome (WKS) is an important disorder for all physicians to recognize, yet thiamine deficiency related to malnutrition or failure to thrive due to psychiatric illness is not a commonly suggested diagnosis or widely discussed in the medical literature. Case Presentation A middle-aged woman with food refusal and apathy related to severe depression
-
Validation of the Ask Suicide-Screening Questions (ASQ) for Adult Medical Inpatients: A Brief Tool for All Ages Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Lisa M. Horowitz, Deborah J. Snyder, Edwin D. Boudreaux, Jian-Ping He, Colin J. Harrington, June Cai, Cynthia A. Claassen, Joan E. Salhany, Tram Dao, John F. Chaves, David A. Jobes, Kathleen R. Merikangas, Jeffrey A. Bridge, Maryland Pao
BACKGROUND Few brief suicide risk screening instruments are validated for use in both adult and pediatric medical populations. Using the pediatric Ask Suicide-Screening Questions (ASQ) development study as a model, this study aimed to determine whether the ASQ is a valid suicide risk-screening instrument for use among adults medical patients, as well as to evaluate a set of other potential screening
-
The Effectiveness of Collaborative Care on Depression Outcomes for Racial/Ethnic Minority Populations in Primary Care: A Systematic Review Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Jennifer Hu, Tina Wu, Swathi Damodaran, Karen M. Tabb, Amy Bauer, Hsiang Huang
BACKGROUND Racial/ethnic minorities experience a greater burden of mental health problems than white adults in the United States. The collaborative care model is increasingly being adopted to improve access to services and to promote diagnosis and treatment of psychiatric diseases. OBJECTIVE This systematic review seeks to summarize what is known about collaborative care on depression outcomes for
-
New-Onset Abnormal Vocalizations in an Adult Woman with Down Syndrome Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Michelle L. Palumbo, James O. Robbins, Michelle Chaney, Christopher Keary, Allison Schwartz, Brian G. Skotko, Christopher J. McDougle
Abstract The case of a 32-year-old woman with Down syndrome (DS) with new-onset abnormal vocalizations as a manifestation of gastroesophageal reflux disease (GERD) is described highlighting the clinical features, differential diagnosis, work-up, results, and treatment course. A broad differential diagnosis, including the contribution of common medical co-morbidities, should be considered in patients
-
Altruistic Renal Donation in a Patient with Dissociative Identity Disorder: A Case Report Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Ariel Claman, Anna Dickerman, Farrah Desrosiers, Marian Charlton, Aliza Perrin Zubov, David Serur
Abstract Altruistic donation is currently a common source of organs for kidney transplantation in the United States. In clinical practice, prospective donors typically undergo psychosocial evaluations to determine their suitability for donation. However, the current guidelines for such assessments contain limited recommendations in regard to specific psychiatric disorders. Here we discuss the case
-
First reported case of anti-N-methyl D-aspartate receptor encephalitis in a child with crossed cerebellar diaschisis and extreme delta brush Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Eric Luria Goldwaser, Sarah Edwards, Aniruddh Ajith, Eric Nagele, Jana Elliker, Margaret Ferris, Stephen J. Thompson
Abstract Background Neuroimaging is an important step in the diagnostic workup of patients with suspected autoimmune encephalitis. Conventional MRI reveals abnormalities roughly half of the time. Functional neuroimaging, including FDG-PET scans, have an increased ability to detect changes in neuronal activity and have superior efficacy at correlating clinical course in NMDARe as well. Case History
-
Psychiatric Symptoms in Pediatric Patients with MOG-IgG-Antibody Positive Autoimmune Encephalitis: A Case Series Psychosomatics (IF 3.4) Pub Date : 2020-11-01 James H. Powers, GenaLynne C. Mooneyham
Abstract Purpose To report the psychiatric symptoms observed in three patients diagnosed with myelin-oligodendrocyte-glycoprotein antibody-positive autoimmune encephalitis (MOG-associated AE). Methods Retrospective chart review and summation of clinical care observations in the treatment of three pediatric patients diagnosed with MOG-associated AE at a tertiary medical institution. Results MOG-associated
-
Non-NMDA autoimmune encephalopathy and catatonia treated with electroconvulsive therapy: A pediatric case series and treatment guidelines Psychosomatics (IF 3.4) Pub Date : 2020-11-01 Nicholas A. Mischel, GenaLynne C. Mooneyham, Cecilia Lau, Heather Van Mater, Richard D. Weiner
Introduction Autoimmune encephalitis (AE) is an inflammatory condition which may present with encephalopathy, including psychiatric symptoms of psychosis and catatonia. When catatonia becomes life-threatening or refractory to medication, electroconvulsive therapy (ECT) should be considered. This case series represents a compilation of patient care experiences in which ECT served as a highly effective
-
Life-Threatening Catatonia Associated With Coronavirus Disease 2019. Psychosomatics (IF 3.4) Pub Date : 2020-10-22 Clara Deocleciano de Araujo,Leandro X C Schlittler,Rodrigo Mantovani Sguario,Daniela Miti Tsukumo,Paulo Dalgalarrondo,Claudio E M Banzato
-
Procedural, Treatment, and Ethics Considerations of Behavioral Emergencies During Coronavirus Disease 2019 and Relaxed Seclusion Guidelines. Psychosomatics (IF 3.4) Pub Date : 2020-10-13 Carmen Black Parker,Amanda Calhoun,Tobias Wasser,Vinneth Carvalho,Charles Dike
-
"A Kratom Konundrum": Management of Kratom Withdrawal With Gabapentin in a Patient With a Left Ventricular Assist Device. Psychosomatics (IF 3.4) Pub Date : 2020-10-13 Nicholas B Giancola,Jason P Caplan,Curtis A McKnight
-
Steroid-Responsive Mania Secondary to Pachymeningitis of the Right Frontal Lobe. Psychosomatics (IF 3.4) Pub Date : 2020-10-03 Ethan A Solomon,Andrew Murphy,Andrew M Siegel,Geoffrey Taylor
-
Semiology in Psychogenic Nonepileptic Seizures: Some Additional Facets. Psychosomatics (IF 3.4) Pub Date : 2020-10-01 Divyani Garg
-
Capacity, revisited: A case report of a patient with guardianship who refuses life prolonging treatment Psychosomatics (IF 3.4) Pub Date : 2020-10-01 Pooja R. Sarkar, Shannon L. Mazur, Peter A. DePergola, Walter J. Kilpatrick
Abstract Introduction Consultation liaison psychiatrists may be asked to evaluate for capacity when a patient with guardianship refuses life-saving treatment. The team and guardian may turn to the Consultation psychiatrist for guidance if they themselves are uncertain of the patient’s true values or underlying wishes. While these consultation requests may be dismissed as unnecessary, we argue there
-
An exploratory analysis of accelerometer-measured physical activity and emotional functioning in patients with chronic pain Psychosomatics (IF 3.4) Pub Date : 2020-10-01 Melinda I. Morrill, Ryan A. Mace, Jonathan Greenberg, Ann Lin, Karmel W. Choi, Ana-Maria Vranceanu
BACKGROUND Physical activity (PA) can benefit pain and emotional functioning for patients with chronic pain. However, associations between different intensities of PA (moderate-to-vigorous PA, light PA, and sedentary behavior), pain, and emotional functioning are not well understood in patients with chronic pain. OBJECTIVE The goals of this study were to (1) describe PA patterns of adult patients with
-
Depression, Anxiety, and Acute Stress Disorder among Patients Hospitalized with COVID-19: A Prospective Cohort Study Psychosomatics (IF 3.4) Pub Date : 2020-10-01 Catherine Parker, Daniel Shalev, Ian Hsu, Akhil Shenoy, Stephanie Cheung, Sara Nash, Ilona Wiener, David Fedoronko, Nicole Allen, Peter A. Shapiro
Objective The epidemiology of psychiatric symptoms among COVID-19 patients is poorly characterized. This paper seeks to identify the prevalence of anxiety, depression, and acute stress disorder among hospitalized patients with COVID-19. Methods Adult patients recently admitted to non-ICU medical ward settings with COVID-19 were eligible for enrollment. Enrolled patients were screened for depression
-
Castration for Hire: Genital Self-Mutilation Performed by Third Party at Patient Request Psychosomatics (IF 3.4) Pub Date : 2020-10-01 Salil Phadnis, Alexis Cohen-Oram, Patrick MacIver
Abstract Male genital self mutilation (GSM) has traditionally been thought to take place primarily in the setting of acute psychosis, however, recent research has suggested a greater prevalence of non-psychotic patients performing GSM for reasons such as reduction of libido, body dysmorphia, and fantasy. We present a unique case in which a 52 year old male seeking castration met an individual in an
-
Diabetic Retinopathy and Depression: A Risk Assessment. Psychosomatics (IF 3.4) Pub Date : 2020-09-28 Tomoyuki Kawada
-
A Call to Action: A New Era Calls for Incorporating Social Justice Into Consultation-Liaison Psychiatry. Psychosomatics (IF 3.4) Pub Date : 2020-09-20 Diana M Robinson,Adrienne D Taylor,Mira Zein,Kayla S Behbahani,Abhisek C Khandai
-
The Use of Therapeutic Metaphor on an Addiction Consult Service. Psychosomatics (IF 3.4) Pub Date : 2020-09-15 David E Marcovitz,Sanchit Maruti,Kristopher A Kast,Joji Suzuki
-
Psychosomatics: That Was Then, This Is Now, and This Is What It Might Be. Psychosomatics (IF 3.4) Pub Date : 2020-09-06 Theodore A Stern
-
CLONAZEPAM FOR CATATONIA INCOMPLETELY RESPONSIVE TO LORAZEPAM Psychosomatics (IF 3.4) Pub Date : 2020-09-01 Shixie Jiang, Kim C. Brownell, Joel E. Kamper, Jonathan T. Stewart
Abstract Purpose Benzodiazepines (BZDs) are a mainstay of treatment of catatonia with response rates of 60 to 80%, but there is virtually no data regarding the relative efficacy of different agents. We report a patient with catatonia who responded incompletely to lorazepam but much more definitively to clonazepam. Procedures Single case report. Findings A 74 year old man with recurrent catatonia had
-
Uncovering physical and attitudinal barriers to adherence to precautions for preventing the transmission of COVID-19 and anxiety level of people in Wuhan: 2 months after the lockdown Psychosomatics (IF 3.4) Pub Date : 2020-09-01 Yulan Lin, Haridah Alias, Xiao Luo, Zhijian Hu, Li Ping Wong
Background Wuhan, the epicentre of the coronavirus diseases (COVID-19) outbreak, has been locked down on January 23, 2020. We aimed to investigate the barriers to the physical prevention, negative attitudes and anxiety levels. Methods A online cross-sectional survey was conducted with the people living in Wuhan between March 12th and 23rd, 2020. Results Of a total of 2,411 complete responses, the mean
-
The Management Experiences, Priorities and Challenges of Medical Directors in the Subspecialty of Consultation-Liaison Psychiatry: Results of a Needs Assessment Psychosomatics (IF 3.4) Pub Date : 2020-09-01 Brian Bronson, Greg Perlman
BACKGROUND Medical directors need management skills; yet, few studies describe the specific tasks that directors consider most important, their confidence for these tasks, and how their confidence develops. We studied these questions among directors in the subspecialty of Consultation-Liaison Psychiatry. METHODS A needs survey was sent to 48 registrants of a new forum for Consultation-Liaison Psychiatry
-
A Case of Concurrent Delirium and Catatonia in a Woman with COVID-19 Psychosomatics (IF 3.4) Pub Date : 2020-09-01 Jamelleh Amouri, Patricia S. Andrews, Stephan Heckers, E. Wesley Ely, Jo Ellen Wilson
Introduction Delirium and catatonia are two representations of acute brain dysfunction that can occur in medically ill patients. It has become increasingly evident that delirium and catatonia can co-occur in the setting of medical illnesses. Delirium and catatonia have been separately described as neuropsychiatric sequelae of Coronavirus Disease 2019 (COVID-19) infection; however, to the best of our
-
Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis Psychosomatics (IF 3.4) Pub Date : 2020-09-01 Nichakarn Yordduangjun, Evan Dishion, Curtis A. McKnight, Jason P. Caplan
Abstract Immune checkpoint inhibitor (ICI) therapy offers an efficacious and novel way to treat many types of cancer. ICIs upregulate the immune system (specifically T-lymphocytes) allowing for better recognition and termination of neoplastic cells. 1 Adverse effects of ICIs are colitis, diarrhea, dermatopathies, endocrinopathies, and other autoimmune pathology. Although less common, neurologic toxicities
-
Stiff Person Syndrome and Psychiatric Comorbidities: A Systematic Review Psychosomatics (IF 3.4) Pub Date : 2020-09-01 Deirdre Caffrey, Christine T. Finn, Seoho Michael Song, Frederick Burton, Cybele Arsan
BACKGROUND Stiff-person syndrome (SPS) is a rare autoimmune neurologic disease characterized by painful rigidity and muscle spasms. Patients with SPS may present with psychiatric symptoms, and little is known about the presence of psychiatric comorbidities. OBJECTIVE The objective of this study was to provide an overview of the association between SPS and psychiatric illnesses. METHODS The protocol
-
Bispectral index monitoring with density spectral array for delirium detection Psychosomatics (IF 3.4) Pub Date : 2020-09-01 Alice Luo, Susan Muraida, Dana Pinchotti, Elizabeth Richardson, Enstin Ye, Bryce Hollingsworth, Alexander Win, Orrin Myers, Jens Langsjoen, Emiliano Valles, Arpad Zolyomi, Davin K. Quinn
BACKGROUND Delirium in hospitalized patients often goes undetected. Cerebral state monitors, which measure limited-channel electroencephalography, have shown potential for improving delirium detection. OBJECTIVE The aim of this study was to compare a FDA-approved cerebral state monitor, bispectral index monitoring with density spectral array (DSA), for delirium identification with clinical screening
-
Clinical Approach to Personality Change Due to Another Medical Condition Psychosomatics (IF 3.4) Pub Date : 2020-09-01 Idris Leppla, Daniel Fishman, Inder Kalra, Mark A. Oldham
BACKGROUND Medical personality change (MPC) is a codable diagnosis (i.e., F07.0) that deserves consideration when a patient is inexplicably no longer "acting like him/herself." Its presentation ranges from subtle to severe and is often characterized by bafflingly poor judgment and impairment in several aspects of a person's life. Despite the global impact that MPC can have on a patient's functioning